Safety and efficacy of siddha medicine preparation in the management of COVID-19: A prospective randomised open label study

• Published in: Journal of ayurveda and integrative medicine 2022-07, Vol.13 (3), p.100597-100597, Article 100597
• Main Authors: Shanmugam, K., Nirmala, A., Parthiban, P., Pitchiah Kumar, M., Dhanam, C., Ganesh, S., Babu, K., Salaikarthikaiyan, T.
• Format: Article
• Language: English
• Subjects: AYUSH; CAM therapy; Clinical trial; COVID-19; Original; Traditional medicine
• ISSN: 0975-9476; 0976-2809
• DOI: 10.1016/j.jaim.2022.100597

The use of complementary and alternative medicine (CAM) therapies has surged since the spread of COVID-19 pandemic. However, the efficacy and safety of these CAM therapies remains majorly unexplored. To understand the efficacy and safety of Nochi Kudineer Chooranam (5 gm), Mahasudarsan Chooranam (3 gm) , Adathodai Manapagu (10 ml), Omatheeneer (10 ml), Maldevi chenduram (100 mg) with honey in management of COVID 19 patients. We conducted a randomised, controlled, open label trial in patients hospitalized with SARS-CoV-2 infection who had an oxygen saturation of 90% or more while breathing ambient air. Patients were randomized into two groups in a 1:1 ratio to either intervention group, receiving seven days of siddha medicine (Intervention group; n = 50) or standard care (control group; n = 50). The primary end point was clinical markers and patient recovery status on day 8. A total of 100 patients with confirmed COVID-19 with average age of 37 yrs (interquartile range, 28–49) participated in the study. There was no statistically difference between groups at baseline (P > 0.05). After intervention, patients in the intervention group had statistically (P